HomeUTHR • NASDAQ
add
United Therapeutics Corporation
Previous close
$355.93
Day range
$346.31 - $358.97
Year range
$208.62 - $366.08
Market cap
15.57B USD
Avg Volume
373.92K
P/E ratio
16.09
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 714.90M | 19.85% |
Operating expense | 317.20M | 44.84% |
Net income | 278.10M | 7.29% |
Net profit margin | 38.90 | -10.47% |
Earnings per share | 5.85 | 11.64% |
EBITDA | 338.60M | 3.77% |
Effective tax rate | 21.73% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.97B | 10.92% |
Total assets | 6.72B | 0.63% |
Total liabilities | 1.03B | -19.23% |
Total equity | 5.70B | — |
Shares outstanding | 44.49M | — |
Price to book | 2.78 | — |
Return on assets | 12.10% | — |
Return on capital | 13.18% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 278.10M | 7.29% |
Cash from operations | 232.20M | 118.44% |
Cash from investing | -80.00M | 64.79% |
Cash from financing | -48.00M | -294.33% |
Net change in cash | 104.20M | 208.32% |
Free cash flow | 80.59M | 746.06% |
About
United Therapeutics Corporation is an American publicly traded biotechnology company and public benefit corporation listed on the NASDAQ under the symbol UTHR. It develops novel, life-extending technologies for patients in the areas of lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
Founded
1996
Headquarters
Website
Employees
1,168
